Actos Lawsuit Update: Bernstein Liebhard LLP Closely Monitoring Nation’s First Actos Bladder Cancer Trial

Share Article

The Firm continues to evaluate potential Actos lawsuits on behalf of patients who developed bladder cancer, allegedly due to long-term use of Actos.

Bernstein Liebhard LLP | Consumer Injury Lawyers
We continue to hear from long-term Actos users who developed bladder cancer while using this drug. We are pleased that these claims are heading to trial.

The first Actos lawsuit involving allegations that the type 2 diabetes drug caused bladder cancer is scheduled to begin today in Los Angeles Superior Court, Bernstein Liebhard LLP reports. The Firm will follow developments in this trial closely, as its outcome may provide valuable insights into how juries could rule in similar Actos lawsuits. (Cooper v. Takeda Pharmaceuticals America, Inc., CGC-12-518535, California Superior Court (Los Angeles))

“We continue to hear from long-term Actos users who developed bladder cancer while using this drug. We are pleased that these claims are heading to trial,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free lawsuit evaluations to individuals who were diagnosed with bladder cancer following long-term use of Actos.

Actos Bladder Cancer Lawsuits
Court records indicate that Takeda Pharmaceuticals, the maker of Actos, faces more than 3,000 lawsuits filed by individuals who allege long-term use of the drug increases the risk for bladder cancer. According to a report from, court filings in the Los Angeles lawsuit show the company secretly surveyed a dozen doctors in 2003 to see if they would use a diabetes drug with their patients that carried a warning about the potential for bladder cancer. Plaintiff’s attorneys assert the survey found that “a bladder cancer warning would destroy the sales of Takeda’s most important drug.”*

The U.S. Food & Drug Administration (FDA) ordered Takeda to add new warnings to the Actos label in June 2011, after a study found that long-term use of the drug increased the risk for bladder cancer.** Since then, further research has confirmed an association between Actos and an increased risk for the disease. Most recently, a study published in the British Diabetic Association journal, “Diabetic Medicine,” found that the risk of bladder cancer was significantly higher in patients using Actos compared with control groups.*** Other studies that have confirmed this association include research published last May in the British Medical Journal which concluded that taking the drug for two years can double the risk of developing bladder cancer. **** Another study published in the Canadian Medical Association Journal in July 2012 found that patients taking Actos face a 22 percent increased risk of developing bladder cancer. *****

The Actos lawsuit scheduled for today’s trial is part of a consolidated litigation underway in California state court. In addition to the California proceeding, more than 1,200 Actos lawsuits are currently pending in a federal multidistrict litigation underway in U.S. District Court, Western District of Louisiana. The first trial in the federal litigation is scheduled to begin in November 2014, followed by the second trial in July 2015. (In re: Actos Product Liability Litigation, MDL No. 2299). According to, additional Actos bladder cancer claims are pending in Illinois state court.

Actos users who developed bladder cancer may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. Learn more about filing an Actos lawsuit by visiting Bernstein Liebhard LLP’s website, For additional information, contact a lawyer at Bernstein Liebhard LLP today at (877) 779-1414.


About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website